Kassira Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Kassira Wealth Management's ABBV Position: Q2 2026 in Review
Kassira Wealth Management reduced its AbbVie (ABBV) stake by 0.57% in Q2 2026, selling an estimated $9.47K and leaving 7,702 shares worth $1.94M. The position accounts for 1.55% of the portfolio, ranked #20.
Kassira Wealth Management first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Kassira Wealth Management held 7,702 shares of AbbVie worth $1.94M as of Q2 2026.
- Kassira Wealth Management sold 44 AbbVie shares in Q2 2026, an estimated $9.47K.
- AbbVie made up 1.55% of Kassira Wealth Management's portfolio in Q2 2026, its #20 holding.
- Kassira Wealth Management first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
- 4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Kassira Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.